Citation:

Kapraun, D., M. Sfeir, R. Pearce, S. Davidson, A. Lumen, A. Dallmann, R. Judson, AND J. Wambaugh. Evaluation of a rapid, generic human gestational dose model (Manuscript). REPRODUCTIVE TOXICOLOGY. Elsevier Science Ltd, New York, NY, 113:172-188, (2022). https://doi.org/10.1016/j.reprotox.2022.09.004

Impact/Purpose:

A generic model of human gestation after thirteen weeks has been developed using modern models of human development and can be used with nearly 1000 chemicals for which there are in vitro-measured chemical-specific TK data and thousands more where there are structure-based predictions of in vitro TK data.

Description:

Chemical risk assessment considers potentially susceptible populations including pregnant women and developing fetuses. Humans encounter thousands of chemicals in their environments, few of which have been fully characterized. Toxicokinetic (TK) information is needed to relate chemical exposure to potentially bioactive tissue concentrations. Observational data describing human gestational exposures are unavailable for most chemicals, but physiologically based TK (PBTK) models estimate such exposures. Development of chemical-specific PBTK models requires considerable time and resources. As an alternative, generic PBTK approaches describe a standardized physiology and characterize chemicals with a set of standard physical and TK descriptors – primarily plasma protein binding and hepatic clearance. Here we report and evaluate a generic PBTK model of a human mother and developing fetus. We used a published set of formulas describing the major anatomical and physiological changes that occur during pregnancy to augment the High-Throughput Toxicokinetics (httk) software package. We simulated the ratio of concentrations in maternal and fetal plasma and compared to literature in vivo measurements. We evaluated the model with literature in vivo time-course measurements of maternal plasma concentrations in pregnant and non-pregnant women. Finally, we prioritized chemicals measured in maternal serum based on predicted fetal brain concentrations. This new model can be used for TK simulations of 859 chemicals with existing human-specific in vitro TK data as well as any new chemicals for which such data become available. This gestational model may allow for in vitro to in vivo extrapolation of point of departure doses relevant to reproductive and developmental toxicity.

URLs/Downloads:

Record Details: